Family Medicine · Lake City, SC
NPI
1669578373
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
276 N Ron McNair Blvd
Lake City, SC, 29560
Phone (843) 394-5471
Groups this clinician bills Medicare through
Medicare paid, 2024
$59K
6,879 services
Medicare patients, 2024
234
Average age 74
Drug cost, 2024
$954K
15,531 prescriptions
Company payments, 2025
$1,575
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel E Decamps was code J1010 (injection, methylprednisolone acetate, 1 mg), 4,480 times for 35 patients. In total Daniel E Decamps billed 6,879 services in 35 codes, and Medicare paid $59K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-05-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 4,480 | 35 | $0.10 | $437 |
| 99213 Office E&M - Established | Office | 580 | 208 | $55.02 | $32K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 572 | 45 | $0.08 | $45.79 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 389 | 163 | $11.11 | $4,324 |
| 36415 Venipuncture Blood Collection | Office | 327 | 153 | $8.65 | $2,829 |
| 99214 Office E&M - Established | Office | 95 | 75 | $74.47 | $7,075 |
| 96372 Injection Administration | Office | 68 | 39 | $9.49 | $645 |
| G0008 Administration of influenza virus vaccine | Office | 47 | 47 | $30.42 | $1,430 |
| 90662 Vaccine Product | Office | 45 | 45 | $73.50 | $3,308 |
| 81001 Clinical Chemistry | Office | 42 | 30 | $3.11 | $131 |
| 87428 Infectious Agent Detection by DNA/RNA | Office | 36 | 32 | $63.14 | $2,273 |
| 17000 Destruction Skin Lesion | Office | 34 | 32 | $45.44 | $1,545 |
| J1040 Injection, methylprednisolone acetate, 80 mg | Office | 15 | 14 | $5.41 | $81.21 |
By year: 2022 $20K for 388 services; 2023 $47K for 1,698 services; 2024 $59K for 6,879 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 327 | 153 | $8.65 | $2,829 |
| 81001 Clinical Chemistry | 42 | 30 | $3.11 | $131 |
| 87428 Infectious Agent Detection by DNA/RNA | 36 | 32 | $63.14 | $2,273 |
Medicare prescription drug claims, 2024
In 2024, the drug Daniel E Decamps prescribed most often to Medicare patients was Alprazolam, with 879 prescriptions and refills. In total Daniel E Decamps wrote 15,531 Medicare prescriptions that cost $954K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alprazolam Generic | 879 | 879 | 127 | $5,475 |
| Atorvastatin Calcium Generic | 648 | 1,503 | 154 | $8,101 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 549 | 549 | 86 | $15K |
| Amlodipine Besylate Generic | 528 | 1,211 | 126 | $4,220 |
| Pantoprazole Sodium Generic | 424 | 764 | 83 | $4,259 |
| Levothyroxine Sodium Generic | 383 | 908 | 82 | $4,180 |
| Omeprazole Generic | 364 | 853 | 80 | $5,812 |
| Gabapentin Generic | 345 | 489 | 73 | $5,422 |
| Lisinopril Generic | 324 | 734 | 65 | $2,188 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 311 | 311 | 48 | $7,218 |
| Metformin Hcl Generic | 308 | 676 | 74 | $2,337 |
| Diclofenac Sodium Generic | 296 | 428 | 71 | $4,641 |
| Meloxicam Generic | 222 | 435 | 54 | $1,352 |
| Tramadol Hcl Generic | 214 | 214 | 41 | $1,472 |
| Escitalopram Oxalate Generic | 202 | 412 | 47 | $2,775 |
Brand drugs: 1,210 claims; generic drugs: 14,247 claims; opioid claims: 1,206.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel E Decamps $1,575 ($1,575 in general payments such as food, travel and fees) from 23 companies. The largest payer was Novo Nordisk Inc with $354.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 13 | $354 |
| AstraZeneca Pharmaceuticals LP AZN | 12 | $302 |
| Abbvie Inc. ABBV | 19 | $234 |
| Amgen Inc. AMGN | 6 | $101 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 5 | $97.16 |
| Exact Sciences Corporation EXAS | 4 | $76.91 |
| Pfizer Inc. PFE | 3 | $49.36 |
| Esperion Therapeutics, Inc. ESPR | 2 | $43.06 |
| Antares Pharma, Inc. | 2 | $37.03 |
| GlaxoSmithKline, LLC. GSK | 2 | $32.27 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.